Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LevoCept for Long-Acting Reversible Contraception
NCT02882191Phase 2Completed
- Sponsor
- Sebela Pharmaceuticals
- Start
- Nov 2016
- Primary completion
- Jul 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of LevoCept in contraception, sponsored by Sebela Pharmaceuticals. Started Nov 2016; status: completed.
02
Drugs
LevoCept
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02882191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882191.